The high expression of CNNM4 is also correlated with high expression of TRPM7 and MAGT1, another magnesium transporter, and this TRPM7/MAGT1/CNNM4 signature is associated with low patient survival in pancreatic adenocarcinoma [43]. Here, TRPM7 is linked to pancreatic adenocarcinoma.